Andreas Dominik Braun

9PUBLICATIONS
27CO-AUTHORS
Molecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 28, 2026
HCA2 Receptors in Lymphocytes and Keratinocytes Affect Murine Contact Allergic Inflammation.

|May 07, 2025
Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy.

Katharina Schumann, Kai Christian Klespe, Cornelia Mauch

|Feb 13, 2025
MCAM Expression Facilitates Melanoma-Endothelial Interactions and Promotes Metastatic Disease Progression.

Andreas Dominik Braun, Miriam Mengoni, Thomas Tüting

|Dec 11, 2024
Liver Metastases are Associated with a Short Post-Progression Survival in a Real-World Group of Patients with Melanoma Treated with Checkpoint Inhibitors.

Miriam Mengoni, Thomas Tüting, Evelyn Gaffal

|Jun 10, 2024
Comprehensive analysis of body composition features in melanoma patients treated with tyrosine kinase inhibitors.

Miriam Mengoni, Andreas Dominik Braun, Mattes Simon Hinnerichs

|May 25, 2024
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade.

Miriam Mengoni, Andreas Dominik Braun, Mattes Simon Hinnerichs

Pageof 2

Frequent Collaborators

5 joint publications

Miriam Mengoni

5 joint publications

Thomas Tüting

2 joint publications

Anthony C Buzzai

2 joint publications

Alexey Surov